[Form 4] McEwen Inc. Insider Trading Activity

Rhea-AI Filing Summary

McEwen Inc. General Counsel Carmen L. Diges reported acquisitions of equity awards tied to the issuer's common stock. On 08/11/2025 she acquired 40,000 stock options with an exercise price of $10.43 and 3,900 restricted stock units. The option award is subject to a vesting schedule that begins on August 11, 2026 and vests in three equal annual installments. Each restricted stock unit represents a contingent right to one share or cash and vests in three equal installments on December 29, 2025, June 29, 2026 and December 29, 2026.

The reporting form shows these holdings as direct beneficial ownership. The filings identify Ms. Diges as an officer serving as General Counsel and Corporate Secretary and list the number of securities beneficially owned following the transactions as 40,000 options and 3,900 RSUs.

Positive

• Officer alignment: Grants provide direct equity exposure for General Counsel, aligning interests with shareholders
• Clear vesting schedules: Options and RSUs include explicit, multi-date vesting terms
• Direct ownership reported: Holdings are reported as Direct (D), improving transparency

Negative

• None.

Insights

Compensation & Equity Plan Specialist

TL;DR: Typical officer equity grant combines time-based options and RSUs to align management with shareholder outcomes.

The grant structure reported is consistent with standard executive compensation: a stock option with a fixed exercise price of $10.43 and a multi-year vesting schedule plus RSUs that convert to shares or cash at the committee's discretion. The option vests in three equal annual installments beginning Aug 11, 2026, which phases potential upside for the officer while retaining long-term retention incentives. The RSU vesting dates are explicit and front-loaded partially in 2025, suggesting near-term retention intent. Impact is routine for governance and compensation monitoring.

Securities Filing Analyst

TL;DR: Form 4 discloses an officer acquisition of 40,000 options and 3,900 RSUs; disclosures are clear and complete on vesting and conversion terms.

The Form 4 clearly lists the transaction date as 08/11/2025, reports direct beneficial ownership, and provides explicit vesting schedules for both instruments. The RSUs explicitly permit settlement in common stock or cash per the award agreement and vest on specified dates in 2025 and 2026. From a disclosure compliance perspective, the filing contains the required material details for these award grants.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Diges Carmen L

(Last) (First) (Middle)

C/O MCEWEN INC.

150 KING STREET WEST, SUITE 2800

(Street)

TORONTO A6 M5H 1J9

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
McEwen Inc. [ MUX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	General Counsel/Corp Sec

3. Date of Earliest Transaction (Month/Day/Year)
08/11/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$10.43	08/11/2025		A		40,000		(1)	08/11/2030	Common Stock	40,000	$0	40,000	D
Restricted Stock Units	(2)	08/11/2025		A		3,900		(3)	(3)	Common Stock	3,900	$0	3,900	D

Explanation of Responses:

1. The option vests in three equal annual installments, beginning August 11, 2026.

2. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock, or the cash value thereof as set forth in the award agreement, in the discretion of the Issuer's Compensation, Nominating & Corporate Governance Committee.

3. The restricted stock units will vest in three equal installments on each of December 29, 2025, June 29, 2026 and December 29, 2026.

	/s/ Carmen L. Diges	08/13/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Carmen L. Diges report on the Form 4 for McEwen Inc. (MUX)?

She reported acquiring 40,000 stock options and 3,900 restricted stock units on 08/11/2025.

What is the exercise price and vesting schedule for the options reported by Carmen Diges (MUX)?

The options have an exercise price of $10.43 and vest in three equal annual installments beginning August 11, 2026.

When do the restricted stock units (RSUs) vest for the reported grant?

The RSUs vest in three equal installments on December 29, 2025, June 29, 2026, and December 29, 2026.

How are the RSUs settled according to the Form 4 for MUX?

Each restricted stock unit represents a contingent right to receive one share of common stock or the cash value in the discretion of the issuer's Compensation, Nominating & Corporate Governance Committee.

What is Carmen Diges's relationship to McEwen Inc. as reported on the Form 4?

She is reported as an officer with the title General Counsel/Corporate Secretary and the transaction is filed as a single reporting person.